Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same author

Factors influencing receipt of specialty neurologic care for patients with Huntington's disease in Colorado.

Clinical parkinsonism & related disorders·2026
Same author

Recruitment Mode Selectivity and Interview Mode Measurement Effects in a Population-Based Assessment of Cognitive Performance.

International journal of methods in psychiatric research·2026
Same author

Ultraprocessed Foods and the Risk of Cognitive Impairment and Dementia in Older US Adults: 2013-2020 Health and Retirement Study.

American journal of public health·2026
Same author

The Dark Matter of Levodopa Pharmacodynamics.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

A Novel Medicare Claims-Based Approach to Identifying Tele-ICU Capability and Utilization Across US Hospitals.

Medical care·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
查看所有相关文章

相关实验视频

Updated: Jul 22, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K

莱卡内马布:在我们跳跃之前,先看看.

James F Burke1, Kevin A Kerber2, Kenneth M Langa2

  • 1From the Division of Health Services Research (J.F.B., K.A.K.), Department of Neurology, Ohio State University, Columbus; and Department of Internal Medicine (K.M.L.), and Department of Neurology (R.L.A., V.K.), University of Michigan, Ann Arbor. james.burke@osumc.edu.

Neurology
|July 21, 2023
PubMed
概括
此摘要是机器生成的。

莱卡尼马布在阿尔茨海默病 (AD) 和轻度认知障碍 (MCI) 中提供了适度的认知益处,但带来了巨大的风险和前所未有的成本. 与现有治疗方法相比,需要进一步的研究来确认其长期的疗效和安全性.

更多相关视频

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

5.6K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

929

相关实验视频

Last Updated: Jul 22, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

5.6K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

929

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学 是一个学科.
  • 老年病的医生 老年病的医生

背景情况:

  • 一种粉样蛋白隔离剂Lecanemab获得了FDA对轻度阿尔茨海默病 (AD) 和轻度认知障碍 (MCI) 的加速批准.
  • 批准源自Clarity第三阶段试验,该试验显示粉样蛋白斑减少和认知能力下降.

研究的目的:

  • 批判性地评估lecanemab在AD和MCI治疗中的益处,危害和成本.
  • 将lecanemab的临床意义与已建立的基准和现有疗法进行比较.

主要方法:

  • 对lecanemab的Clarity第三阶段试验数据的分析.
  • 与lecanemab的效果大小与最小重要的临床差异和胆酶抑制剂的比较.
  • 评估lecanemab的安全性,包括脑和内出血的发生率.
  • 评估lecanemab的预计成本和对医疗保健支出的潜在影响.

主要成果:

  • 莱卡尼马布显示了统计学上显著的认知效应,但效应大小可能没有临床意义.
  • 在试验中,不良事件包括症状性脑 (11%) 和内出血 (0.5%).
  • 如果lecanemab被广泛采用,预计每年医疗保健成本可能达到1200亿美元.

结论:

  • 莱卡尼马布的临床益处相对于其重大危害和前所未有的成本来说似乎很小.
  • 由于药物相互作用,老年患者群体和不同的临床环境,现实世界的风险可能超过试验数据.
  • 需要进一步的证据来确定lecanemab在有效性,安全性和成本效益方面是否优于现有的治疗方法,如多内佩西尔.